News
Cancer Research UK reach agreement with UCB
Cancer Research UK and UCB have announced a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Cancer Research UK and UCB have announced a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials.